Clinical trials
Completed Phase 3 Dwarfism, Pituitary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 6 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 4 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 37 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 8 |
| Pfizer | 6 |
| Ascendis Pharma Endocrinology Division A/S | 4 |
| Eli Lilly and Company | 3 |
| AEterna Zentaris | 2 |
| LG Life Sciences | 2 |
| Ascendis Pharma A/S | 1 |
| Changchun GeneScience Pharmaceutical Co., Ltd. | 1 |
| Daewoong Pharmaceutical Co. LTD. | 1 |
| EMD Serono | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dwarfism, Pituitary | 37 |
| Endocrine System Diseases | 5 |
| Failure to Thrive | 5 |
| Pituitary Diseases | 5 |
| Diabetes Mellitus | 1 |
| Growth Disorders | 1 |
| Obesity | 1 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.